ArticlebioRxiv : the preprint server for biology2025
Damage and Misrepair Signatures: Compact Representations of Pan-cancer Mutational Processes.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Mutational signatures of single-base substitutions (SBSs) characterize somatic mutation processes which contribute to cancer development and progression. However, current mutational signatures do not distinguish the two independent steps that generate SBSs: the initial DNA damage followed by erroneous repair. To address this modelling gap we developed DAMUTA, a hierarchical Bayesian probabilistic model that infers separate signatures for each process, and captures their sample-specific interaction. We applied DAMUTA to 18,974 pan-cancer whole genome sequencing mutation catalogues from 23 cancer types and show that tissue-specificity in mutation patterns is driven largely by variability in damage processes. We also show that misrepair processes are predictive of DNA damage response deficiencies. Unlike existing approaches, DAMUTA distinguishes damage from misrepair contributions, and we demonstrate significant improvements over a mutational-burden baseline or signatures from the COSMIC database. Our analysis reveals a shared pan-cancer pattern of early clonal transition-mutations which shifts to a more uniform substitution pattern consistent with increased reliance on translesion synthesis for damage tolerance. DAMUTA thus generates a compact set of signatures which resolves redundancies of current signature models, disentangles the effects of DNA damage and misrepair processes, and facilitates improved stratification of tumours, while providing a framework towards a unified pan-cancer model of the cellular response to DNA damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.